Search by Drug Name or NDC

    NDC 43598-0458-36 sorafenib 200 mg/1 Details

    sorafenib 200 mg/1

    sorafenib is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Dr.Reddys Laboratories Inc. The primary component is SORAFENIB TOSYLATE.

    Product Information

    NDC 43598-0458
    Product ID 43598-458_8ad2e151-bfb3-30bc-f24b-928f5f626f1d
    Associated GPIs 21533060400320
    GCN Sequence Number 060199
    GCN Sequence Number Description sorafenib tosylate TABLET 200 MG ORAL
    HIC3 V1Q
    HIC3 Description ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS
    GCN 26263
    HICL Sequence Number 033400
    HICL Sequence Number Description SORAFENIB TOSYLATE
    Brand/Generic Generic
    Proprietary Name sorafenib
    Proprietary Name Suffix n/a
    Non-Proprietary Name sorafenib
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/1
    Substance Name SORAFENIB TOSYLATE
    Labeler Name Dr.Reddys Laboratories Inc
    Pharmaceutical Class Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA216073
    Listing Certified Through 2024-12-31

    Package

    NDC 43598-0458-36 (43598045836)

    NDC Package Code 43598-458-36
    Billing NDC 43598045836
    Package 360 TABLET, FILM COATED in 1 BOTTLE (43598-458-36)
    Marketing Start Date 2022-06-08
    NDC Exclude Flag N
    Pricing Information N/A